The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna’s current price is less than $20 below the psychologically significant $50 price level. Traders often focus on these round-numbered levels as support and resistance points for a stock. Traders should expect that Moderna will see another surge in buying if the stock remains above $50 for more than two trading sessions.